Nomograms in the era of personalized oncologic surgery

Abstract

Colorectal cancer remains a leading cause of cancer mortality, and the development of liver metastases represents a pivotal determinant of prognosis. Despite advances in systemic therapy and surgical techniques, survival after liver resection for colorectal liver metastases (CRLM) remains highly variable. The study by Xie et al addresses this challenge by proposing a clinically applicable nomogram that integrates biochemical parameters (γ-glutamyl transferase, chloride, activated partial thromboplastic time) with tumor-related factors (N stage, vascular invasion) to improve overall survival prediction. Using a large single-center cohort of 1059 surgically treated CRLM patients, the authors applied LASSO-Cox regression to identify independent prognostic variables. The resulting model demonstrated strong predictive accuracy in both training and validation cohorts, with decision curve analysis confirming its clinical utility. By combining tumor biology with systemic and host-related factors, the nomogram reflects a multidimensional approach to prognosis and highlights the value of routinely available laboratory markers, enhancing feasibility in real-world and resource-limited settings. Nevertheless, external validation in diverse populations and contemporary treatment contexts remains essential before widespread implementation. This work illustrates the ongoing transition toward personalized, data-driven decision-making in surgical oncology. The proposed model may assist in preoperative risk stratification, tailoring surveillance strategies, guiding adjuvant therapy, and supporting shared decision-making. Further integration of molecular biomarkers and advanced imaging features could enhance its prognostic precision and facilitate translation into routine clinical practice.

Keywords: Nomogram; Colorectal cancer; Liver metastases; Cancer treatment; Prognostic model; Surgical treatment; Long term outcomes

Core Tip: Personalized oncology increasingly depends on integrating quantitative tools into clinical decision-making. The study by Xie et al introduces a nomogram that combines tumor- and host-related factors (including γ-glutamyl transferase, chloride, activated partial thromboplastic time, N stage, and vascular invasion) to predict survival after colorectal liver metastasis resection. Unlike traditional scores such as Fong or Nordlinger models, this LASSO-Cox–based approach reflects biologic and systemic determinants of outcome. Accessibility and interpretability make it promising for daily surgical oncology practice, emphasizing the ongoing shift toward precision-guided, individualized care in metastatic colorectal cancer.